Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
For the nine months, sales was USD 0.00156 million. Net loss was USD 0.390261 million compared to USD 0.765082 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | 0.00% | 0.00% | +33.33% |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 531K | |
+21.58% | 46.93B | |
+37.63% | 39.08B | |
-8.41% | 38.48B | |
+29.68% | 31.01B | |
-13.75% | 26.14B | |
+11.15% | 25.88B | |
+35.63% | 12.53B | |
-6.54% | 11.36B | |
-12.37% | 10.65B |